Molecular determinants of resistance to antiandrogen therapy - sprookjes - yvandenbroek - TriplyDB

Molecular determinants of resistance to antiandrogen therapy

Molecular determinants of resistance to antiandrogen therapy

http://www.wikidata.org/entity/Q28236889

about

Expression of androgen receptor splice variants in prostate cancer bone metastases is associated with castration-resistance and short survival Stress affects a gastrin-releasing peptide system in the spinal cord that mediates sexual function: implications for psychogenic erectile dysfunction.Androgen-regulated genes differentially modulated by the androgen receptor coactivator L-dopa decarboxylase in human prostate cancer cells Androgen receptor variants occur frequently in castration resistant prostate cancer metastases Male germ cell-associated kinase is overexpressed in prostate cancer cells and causes mitotic defects via deregulation of APC/CCDH1 Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis.JARID1B is a histone H3 lysine 4 demethylase up-regulated in prostate cancer Sirtuin 1 is required for antagonist-induced transcriptional repression of androgen-responsive genes by the androgen receptor Huntingtin interacting protein 1 modulates the transcriptional activity of nuclear hormone receptors Leupaxin, a novel coactivator of the androgen receptor, is expressed in prostate cancer and plays a role in adhesion and invasion of prostate carcinoma cells Shepherding AKT and androgen receptor by Ack1 tyrosine kinase Regulation of androgen receptor-mediated transcription by RPB5 binding protein URI/RMP Regulation of androgen receptor transcriptional activity and specificity by RNF6-induced ubiquitination LEF1 in androgen-independent prostate cancer: regulation of androgen receptor expression, prostate cancer growth, and invasion Prohibitin and the SWI/SNF ATPase subunit BRG1 are required for effective androgen antagonist-mediated transcriptional repression of androgen receptor-regulated genes Modulation of androgen receptor transactivation by FoxH1. A newly identified androgen receptor corepressor The RNA helicase p68 is a novel androgen receptor coactivator involved in splicing and is overexpressed in prostate cancer FUS/TLS is a co-activator of androgen receptor in prostate cancer cells Control of prostate cell growth: BMP antagonizes androgen mitogenic activity with incorporation of MAPK signals in Smad1 A histone H2A deubiquitinase complex coordinating histone acetylation and H1 dissociation in transcriptional regulation Insulin-like growth factor 1/insulin signaling activates androgen signaling through direct interactions of Foxo1 with androgen receptor Ligand-specific allosteric regulation of coactivator functions of androgen receptor in prostate cancer cells Melanoma antigen gene protein MAGE-11 regulates androgen receptor function by modulating the interdomain interaction Interferon-inducible ubiquitin E2, Ubc8, is a conjugating enzyme for protein ISGylation Identification of a cell of origin for human prostate cancer Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study New strategies in metastatic prostate cancer: targeting the androgen receptor signaling pathway Development of a second-generation antiandrogen for treatment of advanced prostate cancer Small molecule screening reveals a transcription-independent pro-survival function of androgen receptor in castration-resistant prostate cancer Structure-activity relationship for thiohydantoin androgen receptor antagonists for castration-resistant prostate cancer (CRPC)EBP1, an ErbB3-binding protein, is decreased in prostate cancer and implicated in hormone resistance Specificity and heregulin regulation of Ebp1 (ErbB3 binding protein 1) mediated repression of androgen receptor signalling Prostate cancer stem cells Genome-wide impact of androgen receptor trapped clone-27 loss on androgen-regulated transcription in prostate cancer cells The cell fate determination factor dachshund inhibits androgen receptor signaling and prostate cancer cellular growth Suppression of androgen receptor-mediated gene expression by a sequence-specific DNA-binding polyamide Hormonal control of androgen receptor function through SIRT1 Androgen receptor signaling is required for androgen-sensitive human prostate cancer cell proliferation and survival Molecular mechanisms underlying resistance to androgen deprivation therapy in prostate cancer Cullin 3 Ubiquitin Ligases in Cancer Biology: Functions and Therapeutic Implications

P2860

Q21091046-BFAC81DD-37C4-4A29-BDCC-B95513B5DBF2 Q21143884-CF0D3466-63E8-4F79-BDBC-A294E1D42413 Q21245730-0450B36F-2231-46B5-9FEC-22D8300C3A74 Q21558502-F7A57C84-BDA7-4C63-B11D-8BF338D45CF4 Q24292955-2114E299-CFD5-4C6A-AA1B-3064DF1D2234 Q24295609-D131DFCE-B907-4822-BCB1-017AA944B1E9 Q24301832-6A490DC2-5B3D-4B3D-95D7-838A7D17A202 Q24306066-21291413-6872-45A2-822A-CBF6472942B5 Q24308715-BDA8CD5A-659C-4F2D-A579-FFDD00249646 Q24308733-F67438F4-FEC1-47BB-BF41-547D15D2A6CA Q24308859-976CE585-EED0-465F-BC36-EA9119AA876E Q24311351-5CAA3F60-7507-4B7D-B022-0ABA40ACC3D3 Q24312829-335B0AF1-4B5D-483E-93DE-31ECB0008773 Q24313620-EB917644-DBFE-4ACE-82F0-58650B546B71 Q24314424-3C27EEF4-BEDF-4FB4-9311-0762BD4BFFCC Q24317585-DF859194-0E00-47C3-9081-5C7881629A9A Q24318348-A66E80A6-26B9-46AC-9B88-6603BF2DAD49 Q24337704-3CF9601A-1499-487E-8C0B-A675DF80657C Q24337748-867E1E87-2249-4005-88CA-B4A6567DC155 Q24337802-5F1C5ABA-EB7A-444D-9569-2A09CFBFC941 Q24338711-5B61E826-AB83-4B0F-B8A5-D079E4A19B99 Q24541489-617EB822-6B44-44D8-8DD5-8B141454F8A3 Q24556963-77E03A81-4093-462B-9F4B-9042801EA03B Q24563471-FF451EC0-23CE-421E-AD73-FA68487AC4FE Q24594400-9A404D16-6ACE-44BB-89CB-527B3C39A700 Q24596926-4EE0EA18-384F-4CF4-98AF-3F7F75DCB5A7 Q24603649-F47BDA17-35DE-437B-A844-D0F9D79DB350 Q24605577-A4316B63-B825-48E3-BE2C-5C7CBC1F5E9A Q24620356-4612A542-AF7F-470F-BA93-6CEC96C3C065 Q24635639-A96F43A4-9D3F-431D-9476-2CD69BD4A62D Q24646417-8E30EA4D-2B5B-4D5E-B7BB-EA6B21F4A2E3 Q24650935-DC044262-1459-44F7-A525-ABC1DBE48A10 Q24654712-62E9053A-025F-47C1-B23F-5BB5756F8A3D Q24657502-418EDBE7-82A1-4F19-99EE-9355068E3494 Q24658169-37A6AF8B-4217-49DE-B3A1-35A51CF1AB3E Q24669875-3714EBDC-6C77-4FC6-952D-52C68F683D8F Q24672448-EEAF7349-8CEC-4706-866C-099CD96379E1 Q24793296-7A327E16-0024-4FDB-BC61-09AE32EBD504 Q26739708-1329612D-623D-4713-A5A0-40BE17C28563 Q26747274-5AB23A32-627A-4C34-9F22-AA3B46B42E2D

P2860

Molecular determinants of resistance to antiandrogen therapy

http://www.wikidata.org/entity/Q28236889

description

2004 nî lūn-bûn

@nan

2004 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Molecular determinants of resistance to antiandrogen therapy

@ast

Molecular determinants of resistance to antiandrogen therapy

@en

Molecular determinants of resistance to antiandrogen therapy

@nl

type

label

Molecular determinants of resistance to antiandrogen therapy

@ast

Molecular determinants of resistance to antiandrogen therapy

@en

Molecular determinants of resistance to antiandrogen therapy

@nl

prefLabel

Molecular determinants of resistance to antiandrogen therapy

@ast

Molecular determinants of resistance to antiandrogen therapy

@en

Molecular determinants of resistance to antiandrogen therapy

@nl

P1433

Q28236889-F3D5809C-DCD5-43B8-A687-D7ED4E948B77

P1476

Q28236889-BD7A0956-9737-4CBE-BA94-276F0CFE37D1

P2093

Q28236889-0EA0E0DB-61D2-4972-8153-705C650AB963

Q28236889-1B32FD87-08BF-4B99-A673-9B48D248A0F6

Q28236889-2F1875C1-B4C7-4D7C-AF11-899C646BB0A4

Q28236889-3D93E368-A385-49F8-8F17-07EAE868B7BD

Q28236889-5B01D46A-58D0-4F13-B1D0-109D8C87C060

Q28236889-60648AE5-3B01-42B3-A655-23A5E1E77B66

Q28236889-7FD4D22E-C340-4308-AF03-9A55A98B3B6F

Q28236889-9437B416-2548-4EEE-A48D-D813F1FE28AF

P2888

Q28236889-F68E5AA4-C31F-444D-9029-9DB4857CA1FE

P304

Q28236889-4FE12596-71D8-4BDD-9181-068E43099815

P31

Q28236889-1398EB73-EFE2-4CF6-B7D6-947D2DF0CFAF

P3181

Q28236889-CD5D50D9-ED79-4C7C-8B4D-742D00802DD0

P356

Q28236889-254BFED0-9906-4AE9-B69B-13D2A5840622

P407

Q28236889-62CE3158-41A5-4ACF-8422-1384A6AC52E5

P433

Q28236889-9913B990-3A07-4EAE-BC5F-4D31205B6440

P478

Q28236889-DEAC7732-C73C-4C06-8DEC-180B677B3D37

P577

Q28236889-AA487490-F0EF-4C0D-BA2B-F8AF40869067

P5875

Q28236889-9C0426B4-CE61-4EB8-BF85-E9799972B2E6

P698

Q28236889-4449C069-1F07-4940-9ACD-505CC5D2AD37

P3181

P356

P1433

Nature Medicine

P1476

Molecular determinants of resistance to antiandrogen therapy

@en

P2093

Charles L Sawyers

http://www.w3.org/2001/XMLSchema#string

Charlie D Chen

http://www.w3.org/2001/XMLSchema#string

Chris Tran

http://www.w3.org/2001/XMLSchema#string

Derek S Welsbie

http://www.w3.org/2001/XMLSchema#string

Michael G Rosenfeld

http://www.w3.org/2001/XMLSchema#string

Randy Chen

http://www.w3.org/2001/XMLSchema#string

Robert Vessella

http://www.w3.org/2001/XMLSchema#string

Sung Hee Baek

http://www.w3.org/2001/XMLSchema#string

P2888

P304

33-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

407070

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NM972

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2004-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8936365

http://www.w3.org/2001/XMLSchema#string

P698

14702632

http://www.w3.org/2001/XMLSchema#string